Ionis Pharmaceuticals IONS Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's common stock, shares, outstanding?
- Ionis Pharmaceuticals (IONS) reported common stock, shares, outstanding of $165.9M in Q1 2026.
- How has Ionis Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- Ionis Pharmaceuticals's common stock, shares, outstanding increased by 4.3% year-over-year, from $159.04M to $165.9M.
- What is the long-term trend for Ionis Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's common stock, shares, outstanding has grown at a 3.1% compound annual growth rate (CAGR), from $140.37M to $163.3M.